BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 23945142)

  • 1. The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.
    Kraft S; Jouvin MH; Kulkarni N; Kissing S; Morgan ES; Dvorak AM; Schröder B; Saftig P; Kinet JP
    J Immunol; 2013 Sep; 191(6):2871-8. PubMed ID: 23945142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo.
    Kraft S; Fleming T; Billingsley JM; Lin SY; Jouvin MH; Storz P; Kinet JP
    J Exp Med; 2005 Feb; 201(3):385-96. PubMed ID: 15684326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraspanin CD151 Is a Negative Regulator of FcεRI-Mediated Mast Cell Activation.
    Abdala-Valencia H; Bryce PJ; Schleimer RP; Wechsler JB; Loffredo LF; Cook-Mills JM; Hsu CL; Berdnikovs S
    J Immunol; 2015 Aug; 195(4):1377-87. PubMed ID: 26136426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine hemokinin-1 functions as an endogenous adjuvant for IgE-mediated mast cell inflammatory responses.
    Sumpter TL; Ho CH; Pleet AR; Tkacheva OA; Shufesky WJ; Rojas-Canales DM; Morelli AE; Larregina AT
    J Allergy Clin Immunol; 2015 Apr; 135(4):1019-1030.e8. PubMed ID: 25201259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide suppresses IgE-mast cell-mediated reactions.
    Wang N; McKell M; Dang A; Yamani A; Waggoner L; Vanoni S; Noah T; Wu D; Kordowski A; Köhl J; Hoebe K; Divanovic S; Hogan SP
    Clin Exp Allergy; 2017 Dec; 47(12):1574-1585. PubMed ID: 28833704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA-155 controls mast cell activation by regulating the PI3Kγ pathway and anaphylaxis in a mouse model.
    Biethahn K; Orinska Z; Vigorito E; Goyeneche-Patino DA; Mirghomizadeh F; Föger N; Bulfone-Paus S
    Allergy; 2014 Jun; 69(6):752-62. PubMed ID: 24734904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephedra Herb, Mao, Inhibits Antigen-Induced Mast Cell Degranulation by Induction of the Affinity Receptor for IgE Internalization.
    Nagata Y; Ando H; Sasaki Y; Suzuki R
    Pharm Res; 2021 Apr; 38(4):569-581. PubMed ID: 33754256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CD40 ligand, B cells, and mast cells in peanut-induced anaphylactic responses.
    Sun J; Arias K; Alvarez D; Fattouh R; Walker T; Goncharova S; Kim B; Waserman S; Reed J; Coyle AJ; Jordana M
    J Immunol; 2007 Nov; 179(10):6696-703. PubMed ID: 17982059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro and In Vivo IgE-/Antigen-Mediated Mast Cell Activation.
    Choi HW; Abraham SN
    Methods Mol Biol; 2018; 1799():71-80. PubMed ID: 29956145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Allergic Reaction through Targeting Surface-Bound IgE with Low-Affinity Anti-IgE Antibodies.
    Zhang K; Liu J; Truong T; Zukin E; Chen W; Saxon A
    J Immunol; 2017 May; 198(10):3823-3834. PubMed ID: 28396318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NecroX-5 suppresses IgE/Ag-stimulated anaphylaxis and mast cell activation by regulating the SHP-1-Syk signaling module.
    Li X; Kwon O; Kim DY; Taketomi Y; Murakami M; Chang HW
    Allergy; 2016 Feb; 71(2):198-209. PubMed ID: 26456627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability.
    D'Costa S; Ayyadurai S; Gibson AJ; Mackey E; Rajput M; Sommerville LJ; Wilson N; Li Y; Kubat E; Kumar A; Subramanian H; Bhargava A; Moeser AJ
    J Allergy Clin Immunol; 2019 May; 143(5):1865-1877.e4. PubMed ID: 30439403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rab44 regulates murine mast cell-driven anaphylaxis through kinesin-1-dependent secretory granule translocation.
    Longé C; Bratti M; Kurowska M; Vibhushan S; David P; Desmeure V; Huang JD; Fischer A; de Saint Basile G; Sepulveda FE; Blank U; Ménasché G
    J Allergy Clin Immunol; 2022 Sep; 150(3):676-689. PubMed ID: 35469841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis.
    Wang HN; Ji K; Zhang LN; Xie CC; Li WY; Zhao ZF; Chen JJ
    J Transl Med; 2021 Jun; 19(1):261. PubMed ID: 34130714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
    Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
    Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival of the mouse ES cell-derived mast cell, MEDMC-BRC6, in mast cell-deficient KitW-sh/W-sh mice.
    Shibagaki S; Tahara-Hanaoka S; Hiroyama T; Nakamura Y; Shibuya A
    Int Immunol; 2017 May; 29(5):235-242. PubMed ID: 28431112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration.
    Hou YB; Zhang LN; Wang HN; Zhao ZF; Sun YT; Ji K; Chen JJ
    Int Immunopharmacol; 2020 Jul; 84():106500. PubMed ID: 32311669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPK kinase 3 specifically regulates Fc epsilonRI-mediated IL-4 production by mast cells.
    MacNeil AJ; Yang YJ; Lin TJ
    J Immunol; 2011 Sep; 187(6):3374-82. PubMed ID: 21841136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroandrographolide inhibits IgE-mediated anaphylactic reactions via calcium signaling pathway.
    Che D; Hou Y; Zeng Y; Li C; Zhang Y; Wei D; Hu S; Liu R; An H; Wang Y; Zhang T
    Toxicol Appl Pharmacol; 2019 Mar; 366():46-53. PubMed ID: 30684531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.